References
- Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116(4):640–651
- Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007;47(2):61–71
- Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 2013;33(3):532–541
- de la Paz MF, Stoiber J, de Rezende Couto Nascimento V, et al. Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases. Graefes Arch Clin Exp Ophthalmol 2014;252(1):83–90
- Kiang L, Sippel KC, Starr CE, et al. Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol 2012;130(4):487–492
- Ray S, Khan BF, Dohlman CH, D’Amico DJ. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol 2002;120(5):559–566
- Georgalas I, Kanelopoulos AJ, Petrou P, et al. Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases. Graefes Arch Clin Exp Ophthalmol 2010;248(3):447–450
- Stacy RC, Jakobiec FA, Michaud NA, et al. Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol 2011;129(3):310–316
- Dudenhoefer EJ, Nouri M, Gipson IK, et al. Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation. Cornea 2003;22(5):424–428
- Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009;28(9):989–996
- Gilbert AL, Jakobiec FA, Chodosh J, Eliott D. A comparison of retrokeratoprosthetic membrane and conjunctival inflammatory responses to silicone oil. J Ophthalmic Inflamm Infect 2014;4:15
- Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 2011;46(2):164–168
- Rudnisky CJ, Belin MW, Todani A, et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2012;119(5):951–955
- Munoz-Gutierrez G, Alvarez de Toledo J, Barraquer RI, et al. Post-surgical visual outcome and complications in Boston type 1 keratoprosthesis. Arch Soc Esp Oftalmol 2013;88(2):56–63
- Patel AP, Wu EI, Ritterband DC, Seedor JA. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye (Lond) 2012;26(3):418–425
- Chak G, Aquavella JV. A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea 2010;29(10):1169–1172
- Ciolino JB, Belin MW, Todani A, et al. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013;120(6):1195–1200
- Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009;28(8):896–901
- Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 2012;96(6):776–780
- Garcia JP Jr., Ritterband DC, Buxton DF, De la Cruz J. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography. Cornea 2010;29(9):1031–1035
- Fintelmann RE, Maguire JI, Ho AC, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 2009;28(8):877–878
- Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 2012;31(4):346–349
- Ramchandran RS, Diloreto DA Jr, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology 2012;119(4):674–681
- Aaberg TM, Jr Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology 1998;105(6):1004–1010
- Behlau I, Martin KV, Martin JN, et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol 2014 [Epub ahead of print]
- Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 2009;28(3):321–327
- Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011;118(8):1543–1550
- Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea 2007;26(1):9–15
- Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119(4):484–489
- Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ. Pediatric keratoprosthesis. Ophthalmology 2007;114(5):989–994
- Rachitskaya AV, Moysidis SN, Miller D, et al. Streptococcal endophthalmitis in pediatric keratoprosthesis. Ophthalmology 2013;120(7):1506–1507
- Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in Jordan. Middle East Afr J Ophthalmol 2012;19(1):97–100
- Behlau I, Mukherjee K, Todani A, et al. Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. Biomaterials 2011;32(34):8783–8796
- Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113(12):1479–1496
- Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea 2005;24(8):915–919
- Sunaric-Megevand G, Pournaras CJ. Current approach to postoperative endophthalmitis. Br J Ophthalmol 1997;81(11):1006–1015
- Verdejo-Gomez L, Pelaez N, Gris O, Guell JL. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging 2011;42(6):446–452
- Pujari S, Siddique SS, Dohlman CH, Chodosh J. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea 2011;30(12):1298–1303
- Robert MC, Pomerleau V, Harissi-Dagher M. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol 2013;97(5):573–577
- Zerbe BL, Belin MW, Ciolino JB. Boston Type 1 Keratoprosthesis Study G: results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113(10):1779 e1771–1777
- Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology 2012;119(8):1530–1538
- Kang JJ, de la Cruz J, Cortina MS. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. Cornea 2012;31(12):1436–1440